Apo-Tiotropium 18 mcg

APO-Tiotropium 18 MCG capsules are inhalation medication designed to help manage respiratory conditions. This tiotropium bromide monohydrate formulation is intended for use with a suitable inhaler device.

APO-Tiotropium 18 MCG capsules are generally used for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Tiotropium is a long-acting bronchodilator that helps to relax the muscles around the airways, making it easier to breathe. This medication is not intended for the treatment of acute bronchospasm or asthma.

Common effects of APO-Tiotropium 18 MCG may include dry mouth, throat irritation, and cough. Some users might experience constipation or blurred vision. These effects are typically mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

APO-Tiotropium 18 MCG should be used with caution in individuals with a history of urinary retention, narrow-angle glaucoma, or severe liver impairment. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Keep the capsules out of reach of children and store them as directed.

APO-Tiotropium 18 MCG may interact with other medications, including anticholinergics, antihistamines, and certain antidepressants. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.